Docket Room.
HB 2545·PA·house

An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.

Reported by CommitteeFiled May 27, 2026
Sponsor: Melissa Shusterman (D)
Latest Action

(Remarks see House Journal Page )

Oct 21, 2026

Summary

The bill obligates health insurance policies issued or renewed in Pennsylvania after the law takes effect to include coverage for vaginal estrogen used to treat menopausal symptoms and prevent urinary tract infections. Coverage must encompass all FDA‑approved vaginal estrogen drugs and devices, though insurers may still apply standard medical‑necessity, cost‑sharing and utilization‑review rules. The goal is to improve access to a common therapy for women experiencing menopause.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get an email when HB 2545 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 2545 free

Or ask your AI assistant about HB 2545 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice